investors
Interview: Cayman Chemical validates eXoZymes' technology...
Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter...
investors
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)
One of the biggest challenges of conventional technologies is the long timelines to advance...
interview
The Catalyst Podcast: Interview with CEO Michael Heltzen
The Catalyst Podcast by Igor Rafalovich is available here:...
interview
Inside Biotech podcast (E34): Michael Heltzen interview
Serial entrepreneur Michael Heltzen, CEO of eXoZymes, reveals how his NASDAQ-listed company is...
interview
The challenges of SynBio - by Zachary Karl, PhD
“Some of the challenges in SynBio, are the costs and the timelines. Timeline-wise, it takes a...